Kingdon Capital Management, L.L.C. Fibrogen Inc Transaction History
Kingdon Capital Management, L.L.C.
- $613 Million
- Q4 2024
A detailed history of Kingdon Capital Management, L.L.C. transactions in Fibrogen Inc stock. As of the latest transaction made, Kingdon Capital Management, L.L.C. holds 100,000 shares of FGEN stock, worth $31,000. This represents 0.73% of its overall portfolio holdings.
Number of Shares
100,000Holding current value
$31,000% of portfolio
0.73%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding FGEN
# of Institutions
79Shares Held
37.4MCall Options Held
351KPut Options Held
105K-
Armistice Capital, LLC New York, NY6.8MShares$2.11 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.88MShares$1.82 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA4.62MShares$1.43 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.91MShares$1.21 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.41MShares$746,9910.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $29.1M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...